{
    "clinical_study": {
        "@rank": "111005", 
        "acronym": "COPDprednisone", 
        "arm_group": [
            {
                "arm_group_label": "prednisone and Solumedrol", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo arm versus prednisone"
            }, 
            {
                "arm_group_label": "solumedrol", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo versus solu medrol"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to investigate if there is an effect on exercise performance\n      og of the anti inflammatory drugs prednisone and solu-medrol in patints with chronic\n      obstructive pulmonary disease(COPD)"
        }, 
        "brief_title": "The Effect of Prednisone and Solu-Medrol on Physical Exercise in COPD Patients and Inflammatory Response During and After Exercise", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Exercise Performance in Copd Patients", 
        "condition_browse": {
            "mesh_term": "Pulmonary Disease, Chronic Obstructive"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:FEV1< 60% FEV1/FVC ratio <70 %\n\n          -  able to use a ergometer bike\n\n        Exclusion Criteria: Haemodynamicaly unstable heart conditions\n\n          -  exacerbations before 6 week entry of the study exacerbation during the study period\n             treatment with beta blockers malignancy the last 5 years allergi toward IMP"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01978665", 
            "org_study_id": "2012-004503-13", 
            "secondary_id": "2012-004503-13"
        }, 
        "intervention": {
            "arm_group_label": "prednisone and Solumedrol", 
            "intervention_name": "prednisone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Prednisone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "COPD exercise inflammation prednisone", 
        "lastchanged_date": "November 6, 2013", 
        "location": {
            "contact": {
                "last_name": "Sebastian Karlsson, MD", 
                "phone": "+4531356579"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "state": "NV", 
                    "zip": "2400"
                }, 
                "name": "Bispebjerg Hospital"
            }, 
            "investigator": {
                "last_name": "Sebastian Karlsson, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Effect of Prednisone and Solu-Medrol on Physical Exercise in COPD Patients and the Inflammaroty Response During and After Exercis.", 
        "other_outcome": [
            {
                "measure": "vo2max", 
                "safety_issue": "No", 
                "time_frame": "jan 2013 to july 2013 ( 6 months)"
            }, 
            {
                "measure": "VO2max", 
                "safety_issue": "No", 
                "time_frame": "jan 2013 until july 2013 (6 months)"
            }
        ], 
        "overall_contact": {
            "email": "seblundkarlsson@gmail.com", 
            "last_name": "Sebastian Karlsson", 
            "phone": "+45 23369715"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "effect on muscle power", 
            "safety_issue": "No", 
            "time_frame": "jan 2013 to july 2013 (6 months)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01978665"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bispebjerg Hospital", 
            "investigator_full_name": "Vibeke Backer", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "the inflammatory response", 
            "safety_issue": "No", 
            "time_frame": "jan 2013 to july 2013 (6 months)"
        }, 
        "source": "Bispebjerg Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bispebjerg Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}